082850 — Wooree Bio Co Income Statement

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeSmall CapContrarian

Market Cap
KR₩106bn
Enterprise Value
KR₩177bn
Revenue
KR₩1tn

Annual income statement for Wooree Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,623,383	1,543,312	1,355,056	1,263,944	1,237,198
Cost of Revenue
Gross Profit	100,796	116,480	114,573	116,348	118,804
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,584,385	1,500,480	1,320,673	1,237,948	1,224,321
Operating Profit	38,997	42,832	34,383	25,996	12,878
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	22,224	45,281	32,026	21,729	24,539
Provision for Income Taxes
Net Income After Taxes	16,983	44,041	25,126	18,946	8,227
Minority Interest
Net Income Before Extraordinary Items
Net Income	16,841	33,156	21,822	15,581	4,743
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	17,030	33,606	21,822	15,581	4,743
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	529	706	467	332	127
Dividends per Share